Tekautz, T.M., Fuller, C.E., Blaney, S., Fouladi, M., Broniscer, A., Merchant, T.E., Krasin, M., Dalton, J., Hale, G., Kun, L.E., et al. (2005) Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older with Radiation Therapy and High-Dose Alkylator-Based Chemotherapy. Journal of Clinical Oncology, 23, 1491-1499.
https://doi.org/10.1200/JCO.2005.05.187

has been cited by the following article:

• TITLE: Cure of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: A Case Report

  AUTHORS: Chengming Xu, Congyan Wu, Meiqing Lou, Yaodong Zhao

  KEYWORDS: Atypical Teratoid/Rhabdoid Tumor, Case Report

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.9 No.1, December 31, 2019

  ABSTRACT: Atypical teratoid/rhabdoid tumor (AT/RT) is an embryonic central nervous system tumor. It has a low incidence with a high degree of malignancy and a poor prognosis. Five years ago, we successfully treated a child with AT/RT. Treatment comprised total tumor resection, 6 MV X 3D conformal radiotherapy (DT: 36Gy/18FX) and six courses of chemotherapy, including teniposide 25 mg (qd × 5d), ACNU 25 mg (qd × 1d), vincristine 1 mg (qd × 1d). There was no tumor recurrence after 5 years of follow-up. We adjusted the previous AT/RT regimen to make it more suitable for the individual treatment of this patient, and now the patient has achieved a cure. So we think this regimen is effective and it is worthy of recommendation.